Abstract:OBJECTIVE:To study the effects of BAY-11-7082 on proliferation and apoptosis of U266 cells and its mechanism of action.MATERIALS AND METHODS:Multiple myelomas U266 cells were cultured and divided into control group and gradient-concentration BAY-11-7082 groups (1 μmol/L, 2 μmol/L, 4 μmol/L and 8 μmol/L). Cells in BAY-11-7082 groups were treated with drugs in different concentrations for 4 h, while those in control group were added with an equal volume of solvent. The cell viability was detected via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and lactate dehydrogenase (LDH) release assay was used to detect the cytotoxicity. Furthermore, cells in low-concentration and high-concentration BAY-11-7082 groups were compared with those in control group. The cell proliferation level was evaluated via cell cycle assay, the interleukin-6 (IL-6) level in cells was detected via enzyme-linked immunosorbent assay (ELISA), and the β-catenin protein expression was detected via Western blotting. Moreover, flow cytometry and Hoechst staining were performed to detect the number of apoptotic cells, and the apoptosis level was detected via caspase3 activity and apoptosis-related protein expression. Finally, the levels of p65, p50 and inhibitor kappa B kinase β (IKKβ) were detected via polymerase chain reaction (PCR), and the expressions and changes of phosphorylated (p)-p65 and p-IKKβ were detected via Western blotting.RESULTS:BAY-11-7082 could reduce the U266 cell viability and increase the cytotoxic effect. Based on gradient concentration, 2 μmol/L was selected as the low concentration, while 4 μmol/L was selected as the high concentration. Compared with those in control group, the number of cells in the S and G2/M phases in drug administration groups was significantly decreased, but that in the G0/G1 phase was significantly increased. Besides, the secretion of IL-6 in cells in drug administration groups was significantly decreased compared with that in control group. The β-catenin protein expression was decreased in drug administration groups, and there was also a difference between high concentration group and low concentration group. Flow cytometry and Hoechst staining showed that the proportion of apoptotic cells in drug administration groups was significantly increased. Western blotting and detection of caspase3 activity revealed that the expression and activation of apoptosis-related protein were increased in drug administration groups. It was found in the detection of nuclear factor-κB (NF-κB) pathway that the NF-κB pathway was inhibited in drug administration groups, and there was also a statistically significant difference between high concentration group and low concentration group.CONCLUSIONS:BAY-11-7082 inhibits the proliferation and induces the apoptosis of U266 cells through inhibiting NF-κB pathway.

Cerulenin Changes Apoptosis Related Genes Expression in Multiple Myeloma Cell Line U266

Study on Proliferation Inhibiting and Apoptosis Inducing Effects of Cerulenin on Multiple Myeloma Cells

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Induction of Apoptosis by CDA- Ⅱ on Acute Promyelocytic Leukemia Cells

An Experimental Study on Cerulenin Induced Apoptosis of Human Osteosarcoma Cells

[Relationship Between CD45 Molecule Expression and Apoptotic Sensitivity of Myeloma Cells].

[The Study of FTY720 on Inducing Apoptosis and Autophagy in Multiple Myeloma Cell Line U266].

Dephosphorylation and mitochondrial translocation of cofilin sensitizes human leukemia cells to cerulenin-induced apoptosis via the ROCK1/Akt/JNK signaling pathway.

Apoptosis on U266 Cells Induced by Brucine by Death-Receptor Pathway

[Multiple myeloma cell line U266 apoptosis induced by velcade].

BAY-11-7082 Induces Apoptosis of Multiple Myeloma U266 Cells Through Inhibiting NF-κB Pathway.

The Ceramide Pathway is Involved in the Survival, Apoptosis and Exosome Functions of Human Multiple Myeloma Cells in Vitro

Glucosylceramide Synthase Upregulates Apoptosis-Related Gene Bcl-2 Ex-Pression Via MEK/ERK Signaling Pathway in Leukemia Multidrug-Resis-tant Cell Line

Effect of cerulenin combined with gemcitabine on proliferation and apoptosis in human pancreatic cell line BxPC3

A study on apoptosis-related gene changes using genechip after the suppression of PNAS-2 expression by RNA interference

Study on the effects of proteasome inhibitor PS-341 on apoptosis and expression of cytokines of U266 cells

Set9, NF-κB, and Microrna-21 Mediate Berberine-Induced Apoptosis of Human Multiple Myeloma Cells

Overexpression of PML Induced Apoptosis in Bladder Cancer Cell by Caspase Dependent Pathway.

The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells.

Apoptosis-inducing Effect of Annexin A2 on Multiple Myeloma Cells and Its Related Mechanisms

Scutellarein Selectively Targets Multiple Myeloma Cells by Increasing Mitochondrial Superoxide Production and Activating Intrinsic Apoptosis Pathway.